Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.94 USD | -1.98% | -4.28% | -45.57% |
Jun. 04 | Lake Street Initiates Pulmonx With Buy Rating, $12 Price Target | MT |
May. 01 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
Business Summary
Number of employees: 279
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Interventional Pulmonology
100.0
%
| 54 | 100.0 % | 69 | 100.0 % | +27.98% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
66.9
%
| 32 | 60.5 % | 46 | 66.9 % | +41.34% |
Europe, Middle-East and Africa
20.2
%
| 8 | 15.8 % | 14 | 20.2 % | +62.95% |
Germany
8.0
%
| 6 | 11.0 % | 5 | 8.0 % | -6.93% |
Asia Pacific
4.4
%
| 3 | 5.3 % | 3 | 4.4 % | +5.48% |
Other International
0.6
%
| 0 | 0.3 % | 0 | 0.6 % | +157.42% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ryan Olivera
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 07-12-31 | |
Lauren Cristina
ADM | Chief Administrative Officer | - | 08-12-31 |
Chief Tech/Sci/R&D Officer | - | - | |
Glendon French
BRD | Director/Board Member | 62 | 14-12-17 |
Sarah Huber
SAM | Sales & Marketing | - | - |
Geoffrey Rose
PRN | Corporate Officer/Principal | 50 | 19-12-31 |
John McKune
AUD | Comptroller/Controller/Auditor | - | 20-07-31 |
Lisa Paul
HRO | Human Resources Officer | 60 | - |
Sales & Marketing | 54 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Ferrari
BRD | Director/Board Member | 70 | 07-01-31 |
Glendon French
BRD | Director/Board Member | 62 | 14-12-17 |
Dana Mead
CHM | Chairman | 64 | 10-01-31 |
Daniel Florin
BRD | Director/Board Member | 60 | 19-12-31 |
Thomas Burns
BRD | Director/Board Member | 63 | 20-08-31 |
Director/Board Member | 63 | 20-08-31 | |
Tiffany Sullivan
BRD | Director/Board Member | 49 | 21-07-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,815,760 | 36,877,155 ( 95.01 %) | 0 | 95.01 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.57% | 275M | |
-24.88% | 7.61B | |
+7.04% | 6.63B | |
+15.10% | 5.53B | |
-15.87% | 4.89B | |
+14.96% | 4.17B | |
-21.75% | 3.99B | |
-25.03% | 2.88B | |
+44.01% | 2.38B | |
+1.98% | 2.08B |
- Stock Market
- Equities
- LUNG Stock
- Company Pulmonx Corporation